Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Economic aspects of epilepsy].

A Argumosa1, J L Herranz

  • 1Servicio de Neuropediatría, Hospital Universitario Marqués de Valdecilla, Santander, España.

Revista De Neurologia
|July 25, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Antiepileptic drugs].

Revista de neurologia·2018
Same author

[Rufinamide. A review of its pharmacokinetic and pharmacodynamic properties].

Revista de neurologia·2008
Same author

[Analysis of the cost-effectiveness of treatment for refractory partial epilepsy: a simulation model for pregabalin and levetiracetam].

Revista de neurologia·2007
Same author

[Rational combination therapy in epilepsy. III. Possible associations between antiepileptic drugs].

Revista de neurologia·2007
Same author

[Rational combination therapy in epilepsy. II. Clinical and pharmacological aspects].

Revista de neurologia·2007
Same author

[Rational combination therapy in epilepsy. I. Concepts and foundations].

Revista de neurologia·2007
Same journal

The Correlation Between and Variability of Three Balance Scales in the Assessment of Balance Function in Patients With Ataxia.

Revista de neurologia·2026
Same journal

Surgical Treatment of an Aneurysm in the Subacute Stage of Hemorrhagic Moyamoya Disease: Aneurysm Resection Combined With STA-MCA Bypass: A Case Report.

Revista de neurologia·2026
Same journal

Mapping the Evidence: Central Sleep Apnea Syndromes During Sleep and Stroke-A Scoping Review.

Revista de neurologia·2026
Same journal

Developmental and Epileptic Encephalopathy Due to a Novel <i>ARHGEF9</i> Deletion Variant: Case Series of Two Siblings.

Revista de neurologia·2026
Same journal

P300 Event-Related Potentials as Cognitive Biomarkers in Neurological and Neuropsychiatric Disorders: A Systematic Review.

Revista de neurologia·2026
Same journal

[Effectiveness and Risk of Recurrence of Pulsed Radiofrequency in Trigeminal Neuralgia and Chronic Cluster Headache].

Revista de neurologia·2026
See all related articles

The economic impact of epilepsy is substantial, affecting patients, families, and healthcare systems. Early interventions and pharmacoeconomic evaluations are crucial for managing epilepsy costs.

Area of Science:

  • Neurology
  • Health Economics
  • Pharmacoeconomics

Context:

  • Epilepsy poses significant economic challenges globally, impacting patient employment, treatment costs, and healthcare systems.
  • Economic evaluations are vital for understanding the direct and indirect costs associated with epilepsy.
  • A lack of epidemiological studies in Spain hinders comprehensive economic analysis of epilepsy within the country.

Purpose:

  • To highlight the economic magnitude of epilepsy.
  • To emphasize the importance of pharmacoeconomic evaluations for antiepileptic drugs.
  • To underscore the need for early interventions to mitigate long-term economic repercussions.

Summary:

  • Epilepsy's economic burden is multifaceted, encompassing direct medical expenses and indirect costs like lost productivity.

Related Experiment Videos

  • Antiepileptic drug costs represent a considerable portion of the total economic impact, with potential for future increases.
  • Pharmacoeconomic analyses, including cost-benefit and cost-effectiveness studies, are essential for optimizing resource allocation and justifying the use of new antiepileptic drugs.

    • Impact:

    • The economic impact of epilepsy extends beyond the individual, affecting families and society.
    • Early intervention strategies are recommended to reduce long-term economic and personal consequences for children with epilepsy.
    • Evaluating the cost-effectiveness of new antiepileptic drugs is critical to ensure their value justifies their price.